Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy

Radiotherapy and Oncology

Volumn 50, Issue 1, 1999, Pages 77-84

  Gasińska, Anna ^a   Urbański, Krzysztof ^a   Jakubowicz, Jerzy ^a   Klimek, Małgorzata ^a   Biesaga, Beata ^a   Wilson, George D ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Bromodeoxyuridine labelling index; DNA ploidy; Prognostic factors; Squamous cell carcinoma of the cervix

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CELL KINETICS; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ANEUPLOIDY; ANTIMETABOLITES; BRACHYTHERAPY; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL DIVISION; DIPLOIDY; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FORECASTING; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; S PHASE; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0033016684     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00135-2     Document Type: Article

References (39)

1. Alama A, Merlo F Chiara S, et al. Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma. Eur. J. Cancer 1992;28A:1079-1080.
2. Annual Report on the Results in Gynecological Cancer, Stockholm: Radiumhemmet, FIGO, 1994, p. 22.
3. Atkin NB, Kay R. Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases. Br. J. Cancer 1979;40:210-221.
4. Awwad HK, Khafagy Y, Barsoum M, et al. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: Influence of tumour proliferation. Radiother. Oncol. 1992;25:261-266.
5. Begg AC, McNally NJ, Shrieve DC, et al. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985;6:620-626.
6. Begg AC, Hofland I, van Glabekke M, Bartelink H, Horiot JC. Predictive value of potential doubling time for radiotherapy of head and neck tumour patients: Results from the EORTC co-operative trial 22851. Semin. Radiat. Oncol. 1992;2:22-25.
7. Bolger BS, Cooke TG, Symonds RP, Maclean AB, Stanton PD. Measurements of cell kinetics in cervical tumours using bromodeoxyuridine, Br. J. Cancer. 68 1993;1:166-171.
8. Cole DJ, Brown DC, Crossley E, Alcock CJ, Gatter KC. Carcinoma of the cervix uteri: An assessment of the relationship of tumour proliferation to prognosis. Br. J. Cancer 1992;65:783-785.
9. Courdi A, Tubiana A, Chavaudra N. Malaise. E.P. 1980; Changes in labelling indices of human tumors after irradiation. Int. J. Radiat. Oncol. Biol. Phys. 6:1639-1644.
10. Cox JD. Large-dose fractionation. Cancer 1985;55:2105-2111.
11. Davis JR, Aristizabal S, Way DL, Weiner SA, Hicks MJ, Hagaman RM. DNA ploidy, grade, and stage in prognosis of uterine cervical cancer. Gynecol. Oncol. 1989;32:4-7.
12. Dixon B, Ward AJ, Joslin AF. Pre-treatment 3H-TdR labelling of cervical biopsies: Histology, staging and tumour response to radiotherapy. Clin. Radiol. 1977;28:491-497.
13. Dudziński MR, Haskill SJ, Fowler WC, Currie JL, Walton LA. DNA content in cervical neoplasia and its relationship to prognosis. Obstet. Gynecol. 1987;69:373-377.
14. Dyson JE, Joslin CA, Rothwell RI, Quirke P, Khoury GG, Bird CC. Flow cytometric evidence for the differential radioresponsiveness of aneuploid and diploid cervix tumours. Radiother. Oncol. 1987;8:263-272.
15. Elequin FT, Muggia FM, Ghossein NA, Ager FJ, Krishnaswamy V. Correlation between in vitro labeling indices (LIs) and tumour regression following radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1978;4:207-213.
16. Gasińska A, Urbański K, Dyba T. DNA ploidy and the labelling index as prognostic factors in cervical cancer. 11th Annual Meeting European Society for Therapeutic Radiology and Oncology, 1992, Malmo, Sweden.
17. Jakobsen A. Prognostic impact of ploidy level in carcinoma of the cervix. Am. J. Clin. Oncol. 1984;7:475-480.
18. Kaplan P, Meier EL. Non-parametric estimation for incomplete observations. J. Am. Stat. Assoc. 1958;53:457-481.
19. Lagrange JL, Courdi A, Chauvel P, et al. The labelling index in carcinoma of the uterine cervix: Its correlation with tumour sterilization. Br. J. Radiol. 1992;65:63-65.
20. Levine EL, Renehan A, Gossiel R, et al. Apoptosis, intrinstic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother. Oncol. 1995;37:1-9.
21. Minagawa Y, Kigawa J, Kanamori Y, Itamochi H, Terakawa N. Tumor cell kinetics in elderly patients with cervical cancer. Obstet. Gynecol. 1993;81:610-614.
22. Oka K, Nakano T, Hoshi T. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labelling indices. Cancer 1996;77:2280-2285.
23. Rutgers DH, van der Linden PM, van Peperzeel AH. DNA-flow cytometry of squamous cell carcinoma of the human uterine cervix: The identification of prognostically different subgroups. Radiother. Oncol. 1986;7:249-258.
24. Saunders MI, Dische S, Grosch EJ, et al. Experience with CHART. Int. J. Radiat. Oncol. Biol. Phys. 1991;21:871-878.
25. Steel GG, Bensted JPM. In vitro studies of cell proliferation in tumours. I. Critical appraisal of methods and theoretical consideration. Eur. J. Cancer 1965;1:275-279.
26. Strang P, Eklund G, Stendahl U, Frankendal B. S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix. Anticancer Res. 1987;7:807-810.
27. Tsang RW, Fyles AW, Kirkbride P, et al. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: Correlation between two laboratories and preliminary clinical results. Int. J. Radiat. Oncol. Biol. Phys. 1995;32:1319-1329.
28. Tubiana M, Courdi A. Cell proliferation kinetics in human solid tumors: Relation to probability of metastatic dissemination and long-term survival. Radiother. Oncol. 1989;15:1-18.
29. Urbański K, Karolewski K, Kojs Z, Klimek M, Dyba T. Adjuvant progestagen therapy improves survival in patients with endometrial cancer after hysterectomy. Results of one-institutional prospective clinical trial. Eur. J. Gynaecol. Oncol. 1993;XIV:98-104.
30. West CML. Predictive assays in radiation therapy. Adv. Radiat. Biol. 1994;18:149-180.
31. West CML, Davidson SE, Roberts SA, Hunter RD. The independence of intrinsic radiosensitivity as a prognostic factor for patients response to radiotherapy of carcinoma of the cervix. Br. J. Cancer 1997;76:1184-1190.
32. Wheeler J, Stephens C, Tornos C, et al. ASTRO research fellowship: Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1995;32:1487-1493.
33. Wilson GD, McNally NJ, Dunphy E, Karcher H, Pfragner R. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry 1985;6:641-647.
34. Wilson GD, McNally NJ, Dische S, Saunders MI, Des Rochers C, Lewis AA. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br. J. Cancer 1988;58:423-431.
35. Wilson GD. Limitations if the bromodeoxyuridine technique for measurement of tumour proliferation. Medical Radiology. Current Topics in Clinical Radiobiology of Tumors. Berlin: Springer, 1993.
36. Wilson GD, Dische S, Saunders MI. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother. Oncol. 1995;36:189-197.
37. Zamulaeva I, Podgorodnichenko VK, Guseva LI, Krikunova LI, Saenko AS. Prognostic significance of S-phase fraction detected by antithymidine antibodies in epidermoid cervix carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 1966;36:685-688.
38. Zanetta GM, Katzmann JA, Keeney GL, Kinney WK, Cha SS, Podratz KC. Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma. Gynecol. Oncol. 1992;46:13-19.
39. Zolzer F, Alberti W, Pelzer T, Lamberti G, Hulskamp FH, Streffer C. Changes in S-phase fraction and micronucleus frequency as prognostic factors in radiotherapy of cervical carcinoma. Radiother. Oncol. 1995;36:128-132.